April 1, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Vomiting affected 31% of high-dose participants, while diarrhea occurred in 23% of patients
Tirzepatide may lead to greater average weight loss in some studies
Our semaglutide weight loss programs give Texans dependable guidance and effective results
(2021) 'Glutathione in the brain', International Journal of Molecular Sciences , 22(9), 5010
You don't do the same thing with blood pressure, "Well, I'll come off my blood pressure meds or cholesterol meds, and see how I do. Some patients may be good candidates for medical therapy alone, particularly those with borderline BMI who have access to medication and do not have conditions such as reflux or a history of pancreatitis, which can be worsened by GLP-1s